Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications

Expert Review of Respiratory Medicine

Volumn 10, Issue 9, 2016, Pages 979-990

  Babu, Abraham Samuel ^a   Arena, Ross ^b   Myers, Jonathan ^c   Padmakumar, Ramachandran ^d   Maiya, Arun G ^a   Cahalin, Lawrence P ^e   Waxman, Aaron B ^f   Lavie, Carl J ^g  

^a MANIPAL UNIVERSITY   (India)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c STANFORD UNIVERSITY   (United States)

^d KASTURBA MEDICAL COLLEGE   (India)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

cardiopulmonary exercise testing; Exercise; exercise capacity; pulmonary hypertension

Indexed keywords

CARDIOPULMONARY EXERCISE TEST; ECHOCARDIOGRAPHY; EVALUATION STUDY; EXERCISE TOLERANCE; HEART DISEASE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HUMAN; HYPOXIA; LUNG CIRCULATION; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION; REVIEW; THROMBOEMBOLISM; COMPLICATION; DAILY LIFE ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; EXERCISE TOLERANCE; HUMANS; HYPERTENSION, PULMONARY; QUALITY OF LIFE;

EID: 84983759428     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1080/17476348.2016.1191353     Document Type: Review

References (100)

1. G.Simonneau, M.A.Gatzoulis, I.Adatia, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34–D41.
2. A.O.Mocumbi, F.Thienemann, K.Sliwa A global perspective on the epidemiology of pulmonary hypertension. Can J Cardiol. 2015;31:375–381.
3. N.Galiè, M.Humbert, J.L.Vachiery, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension:the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)endorsed by:Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan 1;37(1):67–119.• A recent evidence-based recommendation for the diagnosis, management, and prognostication of PH.
4. R.Arena, J.Myers, M.Guazzi. The future of aerobic exercise testing in clinical practice:is it the ultimate vital sign? Future Cardiol. 2010;6:325–342.
5. R.Arena, C.J.Lavie, R.V.Milani, et al. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension:an evidence-based review. J Heart Lung Transplant. 2010;29:159–173.
6. R.Arena, M.Guazzi, J.Myers, et al. Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert Rev Respir Med. 2011;5:281–293.
7. R.Arena, J.Myers, M.A.Williams, et al. Assessment of functional capacity in clinical and research settings:a scientific statement from the American Heart Association Committee on Exercise, rehabilitation, and prevention of the council on clinical cardiology and the council on cardiovascular nursing. Circulation. 2007;116:329–343.
8. A.B.Waxman. Exercise physiology and pulmonary arterial hypertension. Prog Cardiovasc Dis. 2012;55:172–179.
9. R.Naeije, N.Chesler. Pulmonary circulation at exercise. Compr Physiol. 2012;2:711–741.• A detailed review on the response of the pulmonary circulation to exercise.
10. R.Arena, L.P.Cahalin, A.Borghi-Silva, et al. The effect of exercise training on the pulmonary arterial system in patients with pulmonary hypertension. Progress Cardiovasc Dis. 2015;57:480–488.
11. R.Naeije, R.Vanderpool, B.P.Dhakal, et al. Exercise-induced pulmonary hypertension:physiological basis and methodological concerns. Am J Respir Crit Care Med. 2013 Mar 15;187(6):576–583.
12. P.Herve, E.M.Lau, O.Sitbon, et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J. 2015 Sep;46(3):728–737.
13. J.J.Tolle, A.B.Waxman, T.L.Van Horn, et al. Exercise-induced pulmonary arterial hypertension. Circulation. 2008 Nov 18;118(21):2183–2189.
14. L.J.Dell’Italia. Anatomy and physiology of the right ventricle. Cardiol Clin. 2012;30:167–187.
15. M.R.Mehra, M.H.Park, M.J.Landzberg, et al. Right heart failure:toward a common language. J Heart Lung Transplant. 2014;33:123–126.
16. F.Haddad, S.A.Hunt, D.N.Rosenthal, et al. Right ventricular function in cardiovascular disease, part I:anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008 Mar 18;117(11):1436–1448.
17. F.Haddad, R.Doyle, D.J.Murphy, et al. Right ventricular function in cardiovascular disease, part II:pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008 Apr 1;117(13):1717–1731.
18. R.Naeije, S.Brimioulle, L.Dewachter. Biomechanics of the right ventricle in health and disease (2013 Grover Conference series). Pulm Circ. 2014;4:395–406.
19. J.D.Roberts, P.R.Forfia. Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography. Pulm Circ. 2011;1:160–181.
20. O.A.Spruijt, F.S.de Man, H.Groepenhoff, et al. The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med. 2015;191(9):1050–1057.
21. A.S.Babu, J.Myers, R.Arena, et al. Exercise testing methods in the evaluation of patients with pulmonary artery hypertension. Expert Rev Cardiovasc Ther. 2013;11:729–737.
22. X.G.Sun, J.E.Hansn, R.J.Oudiz, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104:429–435.•• A seminal paper identifying exercise limitations in pulmonary hypertension.
23. J.M.Morgan, M.Griffiths, R.M.du Bois, et al. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest. 1991;99(3):551–556.
24. J.Tolle, A.Waxman, D.Systrom. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc. 2008;40:3–8.
25. J.Batt, S.S.Ahmed, J.Correa, et al. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2014 Jan;50(1):74–86.
26. A.P.Breda, A.L.Pereira de Albuquerque, C.Jardim, et al. Skeletal muscle abnormalities in pulmonary arterial hypertension. PLoS One. 2014 Dec 2;9(12):e114101.
27. F.J.Meyer, M.M.Borst, C.Zugck, et al. Respiratory muscle dysfunction in congestive heart failure:clinical correlation and prognostic significance. Circulation. 2001;103(17):2153–2158.
28. H.J.Kabitz, A.Schwoerer, H.C.Bremer, et al. Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci (Lond). 2008;114(2):165–171.
29. F.S.de Man, H.W.van Hees, M.L.Handoko, et al. Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med. 2011;183(10):1411–1418.
30. R.M.Fowler, K.R.Gain, E.Gabbay. Exercise intolerance in pulmonary arterial hypertension. Pulm Med. 2012;2012:359204. doi:10.1155/2012/359204.
31. R.Bauer, C.Dehnert, P.Schoene, et al. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med. 2007;101:2366–2369.
32. F.J.Meyer, D.Lossnitzer, A.V.Kristen, et al. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005;25:125–130.
33. R.P.Ramos, J.S.Arakaki, P.Barbosa, et al. Heart rate recovery in pulmonary arterial hypertension:relationship with exercise capacity and prognosis. Am Heart J. 2012;163:580–588.
34. O.A.Minai, R.Gudavalli, S.Mummadi, et al. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;185:400–408.
35. S.Wang, A.B.Aurora, B.A.Johnson, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261–271.
36. F.Potus, S.Malenfant, C.Graydon, et al. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2014;190:318–328.
37. T.Bertero, Y.Lu, S.Annis, et al. Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. J Clin Invest. 2014 Aug 1;124:3514–3528.
38. D.W.Kitzman, L.Groban. Exercise intolerance. Cardiol Clin. 2011;29:461–477.
39. J.Downing, G.J.Balady. The role of exercise training in heart failure. J Am Coll Cardiol. 2011;58:561–569.
40. V.M.Conraads, E.M.Van Craenenbroeck, C.De Maeyer, et al. Unraveling new mechanisms of exercise intolerance in chronic heart failure:role of exercise training. Heart Fail Rev. 2013;18:65–77.
41. M.Guazzi, R.Arena. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol. 2010;7:648–659.
42. J.L.Vachiéry, Y.Adir, J.A.Barberà, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D100–D108.
43. P.Meyer, G.S.Filippatos, M.I.Ahmed, et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation. 2010;121:252–258.
44. M.Guazzi. Pulmonary hypertension in heart failure preserved ejection fraction:prevalence, pathophysiology, and clinical perspectives. Circ Heart Fail. 2014;7:367–377.
45. B.A.Borlaug. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J. 2014;78:20–32.
46. J.Magne, P.Pibarot, P.P.Sengupta, et al. Pulmonary hypertension in valvular disease:a comprehensive review on pathophysiology to therapy from the HAVEC group. JACC Cardiovasc Imaging. 2015;8:83–99.
47. U.Nellessen, G.Inselmann, J.Ludwig, et al. Rest and exercise hemodynamics before and after valve replacement–a combined Doppler/catheter study. Clin Cardiol. 2000;23:32–38.
48. M.Guazzi, V.Adams, V.Conraads, et al. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261–2274.
49. A.M.Ferrazza, D.Martolini, G.Valli, et al. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009;77:3–17.
50. E.Weitzenblum, A.Chaouat, R.Kessler. Pulmonary hypertension in chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2013;81:390–398.
51. W.D.Man, P.Kemp, J.Moxham, et al. Exercise and muscle dysfunction in COPD:implications for pulmonary rehabilitation. Clin Sci (Lond). 2009;117:281–291.
52. F.Maltais, M.Decramer, R.Casaburi, et al. ATS/ERS Ad Hoc Committee on limb muscle dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement:update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:e15–e62.
53. M.F.Oliveira, J.T.Zelt, J.H.Jones, et al. Does impaired O2 delivery during exercise accentuate central and peripheral fatigue in patients with coexistent COPD-CHF? Front Physiol. 2015 Jan;7(5):514. doi:10.3389/fphys.2014.00514.
54. S.Mathur, D.Brooks, C.R.Carvalho. Structural alterations of skeletal muscle in COPD. Front Physiol. 2014 Mar 19; 5:104. doi:10.3389/fphys.2014.00104.
55. R.Arena. Exercise testing and training in chronic lung disease and pulmonary arterial hypertension. Prog Cardiovasc Dis. 2011;53:454–463.
56. A.K.Boutou, G.G.Pitsiou, P.Siakka, et al. Phenotyping exercise limitation in systemic sclerosis:the use of cardiopulmonary exercise testing. Respiration. 2016;91(2):115–123.
57. D.Dumitrescu, R.J.Oudiz, G.Karpouzas, et al. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS One. 2010;5(12):e14293.
58. A.K.Boutou, G.G.Pitsiou, I.Trigonis, et al. Exercise capacity in idiopathic pulmonary fibrosis:the effect of pulmonary hypertension. Respirology. 2011;16(3):451–458.
59. L.Hellebrandová, J.Chlumský, P.Vostatek, et al. Airflow limitation is accompanied by diaphragm dysfunction. Physiol Res. 2016 Apr 12. [Epub ahead of print].
60. A.E.Holland. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options. Chron Respir Dis. 2010;7(2):101–111.
61. A.Faisal, B.J.Alghamdi, C.E.Ciavaglia, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. 2016 Feb 1;193(3):299–309.
62. T.Menzel, S.Wagner, T.Kramm, et al. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension:changes after pulmonary thromboendarterectomy. Chest. 2000;118:897–903.
63. I.M.Lang, G.Simonneau, J.W.Pepke-Zaba, et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb Haemost. 2013 Jul;110(1):83–91.
64. T.Iwase, N.Nagaya, M.Ando, et al. Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension. Heart. 2001;86:188–192.
65. D.Bonderman, A.M.Martischnig, K.Vonbank, et al. Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy. Chest. 2011 Jan;139(1):122–127.
66. G.Claessen, A.La Gerche, S.Dymarkowski, et al. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. J Am Heart Assoc. 2015 Mar 23;4(3):e001602.
67. Fonseca GH, Souza R, Salemi VM, et al. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J. 2012;39:112–118.
68. K.P.Potoka, M.T.Gladwin. Vasculopathy and pulmonary hypertension in sickle cell disease. Am J Physiol Lung Cell Mol Physiol. 2014 Nov 14. [Epub ahead of print]. doi:10.1152/ajplung.00252.2014.
69. R.F.Machado, H.W.Farber. Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders. Clin Chest Med. 2013;34:739–752.
70. A.Anthi, R.F.Machado, M.L.Jison, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med. 2007;175:1272–1279.
71. G.J.Balady, R.Arena, K.Sietsema, et al. Clinician’s guide to cardiopulmonary exercise testing in adults. A scientific statement from the American Heart Association. Circulation. 2010;122:191–225.
72. G.F.Fletcher, P.A.Ades, P.Kligfield, et al. Exercise standards for testing and training:a scientific statement from the American Heart Association. Circulation. 2013;128:873–934.
73. J.Skalski, T.G.Allison, T.D.Miller. The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases. Circulation. 2012;126:2465–2472.
74. M.R.Abumehdi, A.J.Wardle, R.Nazzal, et al. Feasibility and safety of cardiopulmonary exercise testing in children with pulmonary hypertension. Cardiol Young. 2015 Sep;16:1–7.
75. S.O.Pinkstaff, C.D.Burger, J.Daugherty, et al. Cardiopulmonary exercise testing in patients with pulmonary hypertension:clinical recommendations based on a review of the evidence. Exp Rev Resp Med. 2016;10(3):279–295.• An updated evidence-based review on the use of cardiopulmonary exercise testing in diagnosis, prognosis, and therapeutic efficacy.
76. M.Held, M.Grün, R.Holl, et al. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration. 2014;87:379–387.
77. ATS Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.
78. A.E.Holland, M.A.Spruit, T.Troosters, et al. An official European Respiratory Society/American Thoracic Society technical standard:field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428–1446.
79. S.C.Mathai, M.A.Puhan, D.Lam, et al. The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:428–433.
80. R.N.Bellet, L.Adams, N.R.Morris. The 6-minute walk test in outpatient cardiac rehabilitation:validity, reliability and responsiveness – a systematic review. Physiotherapy. 2012;98:277–286.
81. H.Du, P.J.Newton, Y.Salamonson, et al. A review of the six-minute walk test:its implications as a self-administered assessment tool. Eur J Cardiovasc Nurs. 2009;8:2–8.
82. G.Deboeck, G.Niset, J.L.Vachiery, et al. Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J. 2005;26:667–672.
83. D.L.Sherrill. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384–1387.
84. A.M.Srikanth, G.A.D’souza, V.Devaraj, et al. Reference equations for the six-minute walk distance in the Indian population [abstract]. Chest. 2006;130(suppl):119S.
85. H.Poh, P.R.Eastewood, N.M.Cecins, et al. Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology. 2006;11:211–216.
86. J.E.Neal, A.S.Lee, C.D.Burger. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity. Clin Respir J. 2014;8:404–409.
87. R.Sicari, P.Nihoyannopoulos, A.Evangelista, et al. Stress echocardiography xpert consensus statement:European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9:415–437.
88. P.S.Douglas, B.Khandheria, R.F.Stainback, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography:a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol. 2008;51:1127–1147.
89. E.Grünig, H.Tiede, E.O.Enyimayew, et al. Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation. 2013;128:2005–2015.
90. P.Argiento, N.Chesler, M.Mule, et al. Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J. 2010;35:1273–1278.
91. B.A.Maron, B.A.Cockrill, A.B.Waxman, et al. The invasive cardiopulmonary exercise test. Circulation. 2013;127:1157–1164.
92. N.C.Berry, A.Manyoo, W.M.Oldham, et al. Protocol for exercise hemodynamic assessment:performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015 Dec;5(4):610–618.
93. American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518–624.
94. P.Yuan, X.T.Yuan, X.Y.Sun, et al. Exercise training for pulmonary hypertension:a systematic review and meta-analysis. Int J Cardiol. 2014;178C:142–146.
95. R.Buys, A.Avila, V.A.Cornelissen. Exercise training improves physical fitness in patients with pulmonary arterial hypertension:a systematic review and meta-analysis of controlled trials. BMC Pulm Med. 2015;15:40.
96. A.Pandey, S.Garg, M.Khunger, et al. Efficacy and safety of exercise training in chronic pulmonary hypertension:systematic review and meta-analysis. Circ Heart Fail. 2015 Nov;8(6):1032–1043.
97. A.S.Babu, R.Padmakumar, A.G.Maiya, et al. Effects of exercise training on exercise capacity in pulmonary arterial hypertension:a systematic review of clinical trials. Heart Lung Circ. 2016;25(4):333–341.
98. N.Ehlken, M.Lichtblau, H.Klose, et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension:a prospective, randomized, controlled trial. Eur Heart J. 2016 Jan 1;37(1):35–44.
99. N.Ehlken, C.Verduyn, H.Tiede, et al. Economic evaluation of exercise training in patients with pulmonary hypertension. Lung. 2014;192:359–366.
100. R.Arena, J.Myers, D.E.Forman, et al. Should high-intensity-aerobic interval training become the clinical standard in heart failure? Heart Fail Rev. 2013;18:95–105.